Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 41 announcements

Share price
₹1,143.10
Market cap
₹15,859 Cr
Revenue (annual)
₹3,129 Cr
Net profit (annual)
₹619.5 Cr
P/E (TTM)
24.6×Sector 47.4×
Promoter holding
54.14%+0.22% QoQ
FII holding
5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:43 IST NSE
Employee Stock Options

Eris Lifesciences Employee Stock Options

Eris Lifesciences allotted 1,55,264 equity shares upon the exercise of employee stock options under its ESOP-2021 scheme.

14:58 IST NSE
Employee Stock Options

Eris Lifesciences Employee Stock Options

Eris Lifesciences Limited allotted 4,816 equity shares under its ESOP-2017 scheme. This allotment increases the company's total paid-up share capital to Rs. 13,85,83,305.

15:17 IST NSE
Employee Stock Options

Eris Lifesciences Employee Stock Options

Eris Lifesciences allotted 11,233 equity shares under its ESOP scheme. Total paid-up share capital increased to 138,578,489 shares following the allotment.

12:32 IST BSE
Employee Stock Options

Eris Lifesciences Employee Stock Options

Eris Lifesciences allotted 11,233 equity shares under the ESOP-2021 scheme. The total value of the allotment is approximately ₹0.68 Crore.

Value
₹0.76 Cr
12:31 IST NSE
Employee Stock Options

Eris Lifesciences Employee Stock Options

Eris Lifesciences allotted 11,233 equity shares under the ESOP-2021 scheme. The total value of the allotment is approximately ₹0.68 Crore.

Value
₹0.61 Cr
11:43 IST BSE
Employee Stock Options

Eris Lifesciences Employee Stock Options

Eris Lifesciences allotted 24,396 equity shares under its ESOP-2021 Scheme. The allotment raised approximately ₹1.48 Crore, increasing the company's total paid-up share capital.

Value
₹1.48 Cr